Trending Topic

Breast Cancer
29 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Endocrine therapy (ET) has changed the natural history of hormone receptor-positive (HR+) breast cancer (BC) and is the cornerstone of the treatment of HR+ BC. There are several ETs approved for the treatment of BC, including selective oestrogen receptor modulators (SERMs; tamoxifen), aromatase inhibitors (AIs; anastrazole, letrozole and exemestane) and selective oestrogen receptor degraders (SERDs; fulvestrant […]

Domenico D’Ugo, ESSO 40: Hot Topics, What to Expect and Why Should HCPs Register

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Jul 22nd 2021

touchONCOLOGY were delighted to speak with Professor Domenico D’Ugo, President of the European Society of Surgical Oncology (ESSO) one our media partners. He discusses why healthcare professionals should register and attend the ESSO 40 conference in November 2021 in Lisbon and what we can look forward to.

Questions
1. What can we expect from ESSO 40, the 40th Congress of the European Society of Surgical Oncology? (00:16-01:36)
2. Why should healthcare professionals attend the annual meeting in November? (01:36-02:55)
3. What presentations and data are you most looking forward to? (02:55-04:09)
4. What are the current most exciting advances in surgical oncology? (04:09-05:18)

Disclosure: Professor D’Ugo has no financial or non-financial conflicts of interest to declare in relation to this video.

Support: Interview and filming supported by Touch Medical Media. Interview conducted by Sophie Nickelson.

Filmed in coverage of the 2021 ESSO 40 Annual Meeting.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied

This Functionality is for
Members Only

Explore the latest in medical education and stay current in your field. Create a free account to track your learning.

Close Popup